118th Congress · SENATE BILLBILL

S. 1131 — Drug Price Transparency Act of 2023

“A bill to amend title XI of the Social Security Act and title XXVII of the Public Health Service Act to establish requirements with respect to prescription drug benefits.”

Health

Introduced Mar 30, 2023

Last action Mar 30, 2023

Pipeline · Bill → Law

Step 1

Introduced

Mar 30, 2023

Step 2

Referred

Mar 30, 2023

HELP

Step 3

Committee

Step 4

Senate

Step 5

House floor

Step 6

Resolve Changes

Step 7

Signed

SummaryCRS Summary

This bill provides statutory authority for the limitation on which type of prescription drug rebates are exempt from federal anti-kickback laws. Specifically, a rebate from a drug manufacturer to a health insurer or pharmacy benefit manager is exempt only if the rebate (1) is disclosed to the consumer at the point of sale, or (2) is a flat fee paid for pharmacy benefit management services.

Provisions · 2 sectionsIntroduced in Senate

Timeline · 2 actions

Mar 30, 2023

Introduced in Senate

Mar 30, 2023

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.